Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.
Wood DP.
J Urol. 2014 Feb;191(2):348-9. doi: 10.1016/j.juro.2013.10.133. Epub 2013 Oct 29.
PMID:24411846
Amyloidosis of the bladder and association with urothelial carcinoma: report of 29 cases.
Sirohi D, Gandhi J, Amin MB, Luthringer DJ.
Hum Pathol. 2019 Nov;93:48-53. doi: 10.1016/j.humpath.2019.08.011. Epub 2019 Aug 16.
PMID:31425694
Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
Syed M, Mushtaq S, Loya A, Hassan U, Mir K, Hussain M, Hameed M, Sheikh UN.
Ann Diagn Pathol. 2023 Apr;63:152079. doi: 10.1016/j.anndiagpath.2022.152079. Epub 2022 Dec 13.